** = Publikationen gelistet in SCI/SSCI/Pubmed
** Jahn, SW; Jost, PJ
Challenges in integrating molecular profiles into clinical cancer care
MEMO-MAG EUR MED ONC. 2022;
Doi: 10.1007/s12254-022-00838-1
Web of Science
FullText
FullText_MUG
** Klec, C; Knutsen, E; Schwarzenbacher, D; Jonas, K; Pasculli, B; Heitzer, E; Rinner, B; Krajina, K; Prinz, F; Gottschalk, B; Ulz, P; Deutsch, A; Prokesch, A; Jahn, SW; Lellahi, SM; Perander, M; Barbano, R; Graier, WF; Parrella, P; Calin, GA; Pichler, M
ALYREF, a novel factor involved in breast carcinogenesis, acts through transcriptional and post-transcriptional mechanisms selectively regulating the short NEAT1 isoform.
Cell Mol Life Sci. 2022; 79(7): 391
Doi: 10.1007/s00018-022-04402-2
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Pelzmann, B; Hatab, A; Scheruebel, S; Langthaler, S; Rienmueller, T; Sokolowski, A; Gorischek, A; Platzer, D; Zorn-Pauly, K; Jahn, SW; Bauernhofer, T; Schreibmayer, W
Consequences of somatic mutations of GIRK1 detected in primary malign tumors on expression and function of G-protein activated, inwardly rectifying, K+ channels
FRONT ONCOL. 2022; 12: 998907
Doi: 10.3389/fonc.2022.998907
Web of Science
FullText
FullText_MUG
** Singer, CF; Jahn, SW; Rudas, M; Bago-Horvath, Z; Fitzal, F; Abete, L; Moinfar, F; Gnant, M; Filipits, M, , Austrian, Breast, and, Colorectal, Cancer, Study, Group, (ABCSG)
Independent validation of stromal uPA in ABCSG-08: Level 1b evidence for the prognostic value of uPA immunohistochemistry.
Breast. 2022; 64:127-133
Doi: 10.1016/j.breast.2022.05.003
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Suppan, C; Graf, R; Jahn, S; Zhou, Q; Klocker, EV; Bartsch, R; Terbuch, A; Kashofer, K; Regitnig, P; Lindenmann, J; Posch, F; Gerritsmann, H; Jost, PJ; Heitzer, E; Dandachi, N; Balic, M
Sensitive and robust liquid biopsy-based detection of PIK3CA mutations in hormone-receptor-positive metastatic breast cancer patients.
Br J Cancer. 2022; 126(3):456-463
Doi: 10.1038/s41416-021-01601-9
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Riedl, JM; Hasenleithner, SO; Pregartner, G; Scheipner, L; Posch, F; Groller, K; Kashofer, K; Jahn, SW; Bauernhofer, T; Pichler, M; Stöger, H; Berghold, A; Hoefler, G; Speicher, MR; Heitzer, E; Gerger, A
Profiling of circulating tumor DNA and tumor tissue for treatment selection in patients with advanced and refractory carcinoma: a prospective, two-stage phase II Individualized Cancer Treatment trial.
Ther Adv Med Oncol. 2021; 13:1758835920987658
Doi: 10.1177/1758835920987658
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Suppan, C; Zhou, Q; Jahn, S; Graf, R; Klocker, EV; Terbuch, A; Kashofer, K; Posch, F; Gerritsmann, H; Dandachi, N; Heitzer, E; Balic, M
Comparison of liquid biopsy and tissue based detection of PIK3CAmutations in HR positive metastatic breast cancer patients
CANCER RES. 2021; 81(4):
[Poster]
Web of Science
** Jahn, SW; Bösl, A; Tsybrovskyy, O; Gruber-Rossipal, C; Helfgott, R; Fitzal, F; Knauer, M; Balic, M; Jasarevic, Z; Offner, F; Moinfar, F
Clinically high-risk breast cancer displays markedly discordant molecular risk predictions between the MammaPrint and EndoPredict tests.
Br J Cancer. 2020; 122(12):1744-1746
Doi: 10.1038/s41416-020-0838-2
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Jahn, SW; Plass, M; Moinfar, F
Digital Pathology: Advantages, Limitations and Emerging Perspectives.
J Clin Med. 2020; 9(11):
Doi: 10.3390/jcm9113697
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Gerger, A; Riedl, JM; Perakis, S; Pregartner, G; Scheipner, L; Posch, F; Groller, K; Kashofer, K; Jahn, SW; Bauernhofer, T; Pichler, M; Stoger, H; Berghold, A; Hofler, G; Speicher, M; Heitzer, E
Profiling of circulating tumour DNA for treatment selection in patients with advanced and refractory carcinoma: A prospective, two-stage phase II individualized cancer treatment trial.
ANN ONCOL. 2020; 31: S1095-S1096.-ESMO Virtual Congress; SEP 19-OCT 18, 2020; ELECTR NETWORK.
Doi: 10.1016/j.annonc.2020.08.1331
[Onlinepräsentation]
[OPEN ACCESS]
Web of Science
FullText
FullText_MUG
** Kirchhoff, E; Petru, E; Tamussino, K; Jahn, SW; Regitnig, P
Mucinous Ovarian Cancer: A separate Entity.
GEBURTSH FRAUENHEILK. 2020; 80(4):438-439.-XXVIII. Wissenschaftliche Tagung der Arbeitsgemeinschaft für Gynäkologische Onkologie (AGO) der OEGGG 2020
; APR 23-25,2020; Salzburg, AUSTRIA.
Doi: 10.1055/s-0039-3403410
[Poster]
Web of Science
FullText
FullText_MUG
** Riedl, J; Perakis, S; Pregartner, G; Scheipner, L; Posch, F; Groller, K; Kashofer, K; Jahn, SW; Bauernhofer, T; Pichler, M; Stoger, H; Berghold, A; Hofler, G; Speicher, M; Heitzer, E; Gerger, A
Individualized cancer treatment based on molecular profiling of circulating tumor DNA in patients with advanced and refractory carcinoma: a prospective phase II trial.
ONCOL RES TREAT. 2020; 43(SUPPL 4):249-249.-DGHO Jahrestagung; 09.10. -11.10.2020; Basel (virtueller Kongress).
[Oral Communication]
Web of Science
Christoph Suppan, Qing Zhou, Stephan Jahn, Ricarda Graf, Eva Valentina Klocker, Angelika Terbuch, Karl Kashofer, Florian Posch, Hanno Gerritsmann, Nadia Dandachi, Ellen Heitzer, Marija Balic
Comparison of liquid biopsy and tissue based detection ofPIK3CAmutations in HR positive metastatic breast cancer patients.
SABCS 2020. 2020; -SABCS 2020; DEC 8-11, 2020; SAN ANTONIO, TEXAS, USA.
[Poster]
Taumberger, N; Greimel, P; Schütz, A; Hochstätter, R; Eisnecker, K; Nanda, M; Kurleto, M; Bracic, T; Jahn, S; Tamussino, K; Klaritsch, P
Arteriovenous malformation following uterine scar pregnancy.
Ultrasound Obstet Gynecol 2020; 56 (Suppl. 1): 57–378.. 2020; 56(267):268--30th ISUOG Virtual World Congress; OKT 16-18; London, UK.
** Schratter, G; Scheruebel, S; Langthaler, S; Ester, K; Pelzmann, B; Ghaffari-Tabrizi-Wizsy, N; Rezania, S; Gorischek, A; Platzer, D; Zorn-Pauly, K; Ahammer, H; Prokesch, A; Stanzer, S; Devaney, TTJ; Schmidt, K; Jahn, SW; Prassl, R; Bauernhofer, T; Schreibmayer, W;
GIRK1 triggers multiple cancer-related pathways in the benign mammary epithelial cell line MCF10A.
SCI REP. 2019; 9: 19277
Doi: 10.1038/s41598-019-55683-w
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Schwarzenbacher, D; Klec, C; Pasculli, B; Cerk, S; Rinner, B; Karbiener, M; Ivan, C; Barbano, R; Ling, H; Wulf-Goldenberg, A; Stanzer, S; Rinnerthaler, G; Stoeger, H; Bauernhofer, T; Haybaeck, J; Hoefler, G; Jahn, SW; Parrella, P; Calin, GA; Pichler, M
MiR-1287-5p inhibits triple negative breast cancer growth by interaction with phosphoinositide 3-kinase CB, thereby sensitizing cells for PI3Kinase inhibitors.
Breast Cancer Res. 2019; 21(1): 20-20.
Doi: 10.1186/s13058-019-1104-5
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Singer, CF; Filipits, M; Jahn, SW; Abete, L; Jakesz, R; Greil, R; Bauernhofer, T; Kwasny, W; Seifert, M; Fitzal, F; Kastner, M; Schmitt, M; Moinfar, F; Gnant, M
Stromal coexpression of uPA/PAI-1 protein predicts poor disease outcome in endocrine-treated postmenopausal patients with receptor-positive early breast cancer.
Breast. 2019; 46(14):101-107
Doi: 10.1016/j.breast.2019.05.007
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Terzic, J; Fillafer, F; Posch, F; Pichler, R; Seles, M; Niedersuss-Beke, D; Tinchon, C; Loidl, W; Pichler, M; Jahn, S; Stoger, H; Bauernhofer, T;
Lymphopenia impairs response to 1st-line tyrosine kinase inhibitor therapy in patients with metastatic clear-cell renal cell carcinoma and modulates the relative efficacy of sunitinib and pazopanib
WIEN KLIN WOCHENSCHR. 2019; 131: S447-S447.-Frühjahrstagung der OeGHO; APR 11-13, 2019; Linz, AUSTRIA.
[Poster]
Web of Science
FullText
Klec, C; Schwarzenbacher, D; Resel, M; Rinner, B; Haybaeck, J; Höfler, G; Jahn, SW; Bauernhofer, T; Stöger, H; Pichler, M
miR-1287-5p inhibits triple negative breast cancer growth by interacting with phosphoinositide 3-kinase CB, thereby sensitizing cells for PI3Kinase inhibitors
ÖGHO Frühjahrstagung 2019. 2019; -ÖGHO Frühjahrstagung; 11.-13.April; Linz, AUSTRIA.
[Poster]
Klec, C; Schwarzenbacher, D; Resel, M; Rinner, B; Haybaeck, J; Höfler, G; Jahn, SW; Bauernhofer, T; Stöger, H; Pichler, M
miR-1287-5p inhibits triple negative breast cancer growth by interacting with phosphoinositide 3-kinase CB, thereby sensitizing cells for PI3Kinase inhibitors
ÖGHO Frühjahrstagung 2019. 2019; -ÖGHO Frühjahrstagung 2019; 11.-13.April; Linz, AUSTRIA.
[Oral Communication]
Wienerroither, V; Wolf, G. Simon, A; Jahn, SW; Mischinger, HJ; Mache, C
Primary hyperparathyroidism in a 14-year-old male: A case report
Keine. 2019; -60. Österreichischer Chirurgenkongress; JUN 19-21, 2019; Innsbruck, AUSTRIA.
[Poster]
** Terzic, J; Fillafer, F; Posch, F; Pichler, R; Seles, M; Pichler, M; Jahn, S; Stöger, H; Bauernhofer, T
Lymphopenia impairs response to 1st-line therapy with
sunitinib and pazopanib in patients with metastatic clear-cell
renal cell carcinoma.
Oncology Research
and Treatment . 2018; 41(Suppl4):42-43.-Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie,; SEP 28- OCT 2, 2018; Vienna, AUSTRIA. (ISBN: 978-3-318-06425-4 )
[Oral Communication]
Web of Science
FullText
** El-Heliebi, A; Kashofer, K; Fuchs, J; Jahn, SW; Viertler, C; Matak, A; Sedlmayr, P; Hoefler, G
Visualization of tumor heterogeneity by in situ padlock probe technology in colorectal cancer.
Histochem Cell Biol. 2017; 148(2):105-115
Doi: 10.1007/s00418-017-1557-5
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Al-Zoughbi, W; Pichler, M; Gorkiewicz, G; Guertl-Lackner, B; Haybaeck, J; Jahn, SW; Lackner, C; Liegl-Atzwanger, B; Popper, H; Schauer, S; Nusshold, E; Kindt, AS; Trajanoski, Z; Speicher, MR; Haemmerle, G; Zimmermann, R; Zechner, R; Vesely, PW; Hoefler, G
Loss of adipose triglyceride lipase is associated with human cancer and induces mouse pulmonary neoplasia.
Oncotarget. 2016; 7(23):33832-33840
Doi: 10.18632/oncotarget.9418
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Jahn, SW; Kashofer, K; Thüringer, A; Abete, L; Winter, E; Eidenhammer, S; Viertler, C; Tavassoli, F; Moinfar, F
Mutation Profiling of Usual Ductal Hyperplasia of the Breast Reveals Activating Mutations Predominantly at Different Levels of the PI3K/AKT/mTOR Pathway.
Am J Pathol. 2016; 186(1):15-23
Doi: 10.1016/j.ajpath.2015.09.004
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Kammerer, S; Jahn, SW; Winter, E; Eidenhammer, S; Rezania, S; Regitnig, P; Pichler, M; Schreibmayer, W; Bauernhofer, T
Critical evaluation of KCNJ3 gene product detection in human breast cancer: mRNA in situ hybridisation is superior to immunohistochemistry.
J Clin Pathol. 2016; 69(12):1116-1121
Doi: 10.1136/jclinpath-2016-203798
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Kammerer, S; Sokolowski, A; Hackl, H; Platzer, D; Jahn, SW; El-Heliebi, A; Schwarzenbacher, D; Stiegelbauer, V; Pichler, M; Rezania, S; Fiegl, H; Peintinger, F; Regitnig, P; Hoefler, G; Schreibmayer, W; Bauernhofer, T
KCNJ3 is a new independent prognostic marker for estrogen receptor positive breast cancer patients.
Oncotarget. 2016; 7(51):84705-84717
Doi: 10.18632/oncotarget.13224
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Rezania, S; Kammerer, S; Li, C; Steinecker-Frohnwieser, B; Gorischek, A; DeVaney, TT; Verheyen, S; Passegger, CA; Tabrizi-Wizsy, NG; Hackl, H; Platzer, D; Zarnani, AH; Malle, E; Jahn, SW; Bauernhofer, T; Schreibmayer, W
Overexpression of KCNJ3 gene splice variants affects vital parameters of the malignant breast cancer cell line MCF-7 in an opposing manner.
BMC Cancer. 2016; 16(1):628-628
Doi: 10.1186/s12885-016-2664-8
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Stanta, G; Jahn, SW; Bonin, S; Hoefler, G
Tumour heterogeneity: principles and practical consequences.
Virchows Arch. 2016; 469(4):371-384
Doi: 10.1007/s00428-016-1987-9
Web of Science
PubMed
FullText
FullText_MUG
** Ulz, P; Thallinger, GG; Auer, M; Graf, R; Kashofer, K; Jahn, SW; Abete, L; Pristauz, G; Petru, E; Geigl, JB; Heitzer, E; Speicher, MR
Inferring expressed genes by whole-genome sequencing of plasma DNA.
Nat Genet. 2016; 48(10):1273-1278
Doi: 10.1038/ng.3648
Web of Science
PubMed
FullText
FullText_MUG
** Kashofer, K; Jahn, S; Halbwedl, I; Hoetler, G
Beyond BRCA-HRD scoring using Affymetrix Oncoscan microarrays
VIRCHOWS ARCH. 2016; 469: S203-S203.
[Poster]
Web of Science
** Singer, CF; Filipits, M; Jahn, S; Abete, L; Jakesz, R; Greil, R; Bauernhofer, T; Kwasny, W; Seifert, M; Fitzal, F; Schmitt, M; Moinfar, F; Gnant, M
Stromel co-expression of urokinase-type plasminogen activator (uPA) and plasminogen activator Inhibitor (PAI-1) protein by IHC predicts poor disease outcome in endocrine-treated postmenopausal patients with receptor-positive early breast cancer
CANCER RES. 2016; 76: -38th Annual CTRC-AACR San Antonio Breast Cancer Symposium; DEC 08-12, 2015; San Antonio, TX.
Doi: 10.1158/1538-7445.SABCS15-P2-08-21
[Poster]
Web of Science
FullText
FullText_MUG
Heitzer, E; Ulz, P; Thallinger, GG; Auer, M; Kashofer K; Jahn, SW; Abete L; Pristauz, G; Petru, E; Geigl,JB; Speicher, MR.
Inferring expressed genes by whole-genome sequencing of plasma DNA.
https://ep70.eventpilot.us/web/planner.php?id=ASHG16. 2016; -ASHG 2016; OCT 18-22, 2016; vancouver Kanada.
[Poster]
FullText
** Jahn, SW; Kashofer, K; Halbwedl, I; Winter, G; El-Shabrawi-Caelen, L; Mentzel, T; Hoefler, G; Liegl-Atzwanger, B
Mutational dichotomy in desmoplastic malignant melanoma corroborated by multigene panel analysis.
Mod Pathol. 2015; 28(7):895-903
Doi: 10.1038/modpathol.2015.39
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Li, C; Rezania, S; Kammerer, S; Sokolowski, A; Devaney, T; Gorischek, A; Jahn, S; Hackl, H; Groschner, K; Windpassinger, C; Malle, E; Bauernhofer, T; Schreibmayer, W
Piezo1 forms mechanosensitive ion channels in the human MCF-7 breast cancer cell line.
Sci Rep. 2015; 5(2):8364-8364
Doi: 10.1038/srep08364
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Ress, AL; Stiegelbauer, V; Winter, E; Schwarzenbacher, D; Kiesslich, T; Lax, S; Jahn, S; Deutsch, A; Bauernhofer, T; Ling, H; Samonigg, H; Gerger, A; Hoefler, G; Pichler, M
MiR-96-5p influences cellular growth and is associated with poor survival in colorectal cancer patients.
Mol Carcinog. 2015; 54(11):1442-1450
Doi: 10.1002/mc.22218
Web of Science
PubMed
FullText
FullText_MUG
** Matak, A; Jahn, S; Viertler, C; Thuringer, A; Halbwedl, I; Langner, C; Hoefler, G; Kashofer, K
Genetic heterogeneity of colorectal carcinoma in NGS analysis: A complication for molecular diagnosis?
VIRCHOWS ARCH. 2015; 467: S166-S167.-European Congress of Pathology; SEP 5-9, 2015; Belgrade, SERBIA.
[Poster]
Web of Science
** Singer, CF; Filipits, M; Jahn, S; Abete, L; Jakesz, R; Greil, R; Bauernhofer, T; Kwasny, W; Seifert, M; Fitzal, F; Schmitt, M; Moinfar, F; Gnant, M
Influence of immunohistological detection of intratumoral urokinase-type plasminogen activator (uPA) on disease outcome in endocrine-treated postmenopausal patients with hormone receptor-positive early breast cancer.
J CLIN ONCOL. 2015; 33(15):
Doi: 10.1200/jco.2015.33.15_suppl.551
[Poster]
Web of Science
FullText
FullText_MUG
Kammerer, S; Sokolowski, A; Hackl, H; Platzer, D; Jahn, SW; Peintinger, F; Symmans, F; Schreibmayer, W; Bauernhofer, T.
GIRK1 overexpression correlates with ER positive breast cancer subtypes and is associated with poor prognosis.
Annals of Oncology 2015;26(Supplement 3):15-24. 2015; 26(Supplement 3): 22--IMPAKT 2015 Breast Cancer Meeting; MAY 7-9, 2015; Brussels, BELGIUM.
[Poster]
Ulz, P; Auer, M; Belic, J; Lafer I; Jahn, SW; Pristauz, G; Heidary, M; Schwarzbraun, T; Fischereder K; Gerger, A; Hoefler; G; Augustin, H; Bauernhofer, T; Petru, E; Heitzer, E; Geigl, JB; Speicher, MR
Circulating tumor DNA sequencing reveals cancer driver genes and their plasticity
in focal amplifications
Medizinische Genetik. 2015; 27(1):79-109.-26. Jahrestagung der Deutschen Gesellschaft für Humangenetik gemeinsam mit der Österreichischen Gesellschaft für Humangenetik und der Schweizerischen Gesellschaft für Medizinische Genetik; APR 15-17, 2015; Graz, AUSTRIA.
[Oral Communication]
FullText
** Pichler, M; Ress, AL; Winter, E; Stiegelbauer, V; Karbiener, M; Schwarzenbacher, D; Scheideler, M; Ivan, C; Jahn, SW; Kiesslich, T; Gerger, A; Bauernhofer, T; Calin, GA; Hoefler, G
MiR-200a regulates epithelial to mesenchymal transition-related gene expression and determines prognosis in colorectal cancer patients.
Br J Cancer. 2014; 110(6):1614-1621
Doi: 10.1038/bjc.2014.51
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Auer, M; Heitzer, E; Ulz, P; Pristauz, G; Petru, E; Jahn, S; Speicher, MR; Geigl, JB;
Whole-genome sequencing of plasma DNA reveals frequently occurring copy number changes in patients with metastatic breast cancer.
EUR J CANCER. 2014; 50: S153-S153.-EACR; München.
Doi: 10.1016/S0959-8049(14)50562-X
[Oral Communication]
Web of Science
FullText
FullText_MUG
** Kammerer, S; Sokolowski, A; Hackl, H; Jahn, S; Asslaber, M; Symmans, F; Peintinger, F; Regitnig, P; Schreibmayer, W; Bauernhofer, T
OVEREXPRESSION OF G PROTEIN-ACTIVATED INWARD RECTIFIER POTASSIUM CHANNEL 1 (GIRK1) IS ASSOCIATED WITH LYMPH NODE METASTASIS AND POOR PROGNOSIS IN BREAST CANCER
ANN ONCOL. . 2014; 25: -IMPAKT Breast Cancer Conference; MAY 08-10, 2014; Brussels, BELGIUM.
Doi: 10.1093/annonc/mdu066.21
[Poster]
Web of Science
FullText
FullText_MUG
Auer, M; Heitzer, E; Ulz, P; Petru, E; Pristauz, G; Jahn, S; Speicher, MR; Geigl, JB
Whole-genome sequencing of plasma DNA reveals frequently occurring copy number changes in patients with metastatic breast cancer
http://gfhev.de/de/kongress/GfH_Tagung_2014_Abstractbook.pdf. 2014; -25. Jahrestagung der Deutschen Gesellschaft für Humangenetik; MARCH 19-21, 2014; Essen, GERMANY.
[Poster]
Auer, M; Heitzer, E; Ulz, P; Pristauz, G; Petru, E; Jahn, S; Speicher, MR; Geigl JB
Low coverage whole-genome sequencing of plasma DNA reveals frequently occurring copy number changes in patients with metastatic breast cancer
http://eacr23.eacr.org/. 2014; -23rd Biennal Congress of the European Association of Cancer Research; JULY 4 - 8, 2014; Munich, GERMANY.
[Poster]
** Heitzer, E; Lax, S; Lafer, I; Müller, SM; Pristauz, G; Ulz, P; Jahn, S; Högenauer, C; Petru, E; Speicher, MR; Geigl, JB
Multiplex genetic cancer testing identifies pathogenic mutations in TP53 and CDH1 in a patient with bilateral breast and endometrial adenocarcinoma.
BMC Med Genet. 2013; 14(1):129-129
Doi: 10.1186/1471-2350-14-129
(- Case Report)
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Jahn, S; Zollner, G; Lackner, C; Stauber, RE
Severe toxic hepatitis associated with dronedarone.
Curr Drug Saf. 2013; 8(3):201-202
Doi: 10.2174/15748863113089990031
(- Case Report)
PubMed
FullText
FullText_MUG
** Zeimet, AG; Reimer, D; Huszar, M; Winterhoff, B; Puistola, U; Azim, SA; Müller-Holzner, E; Ben-Arie, A; van Kempen, LC; Petru, E; Jahn, S; Geels, YP; Massuger, LF; Amant, F; Polterauer, S; Lappi-Blanco, E; Bulten, J; Meuter, A; Tanouye, S; Oppelt, P; Stroh-Weigert, M; Reinthaller, A; Mariani, A; Hackl, W; Netzer, M; Schirmer, U; Vergote, I; Altevogt, P; Marth, C; Fogel, M
L1CAM in early-stage type I endometrial cancer: results of a large multicenter evaluation.
J Natl Cancer Inst. 2013; 105(15): 1142-1150.
Doi: 10.1093/jnci/djt144
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Auer, M; Heitzer, E; Ulz, P; Pristauz, G; Petru, E; Jahn, S; Lafer, I; Pantel, K; Speicher, MR; Geigl, JB
Complex tumor genomes inferred from plasma DNA of patients with metastatic breast cancer by whole-genome sequencing
EUR J CANCER. 2013; 49: S399-S399.-17th ECCO / 38th ESMO / 32nd ESTRO European Cancer Congress on Reinforcing Multidisciplinarity; SEP 27-OCT 01, 2013; Amsterdam, NETHERLANDS.
[Oral Communication]
Web of Science
Auer, M; Heitzer, E; Ulz, P; Pristauz, G; Petru, E; Jahn, S; Lafer, I; Pantel, K; Riethdorf, S; Speicher, MR; Geigl, JB
Complex tumor genomes inferred from plasma DNA of patients with metastatic breast cancer by whole-genome sequencing.
http://www.ecco-org.eu. 2013; -The European Cancer Congress 2013 (ECCO17 - ESMO38 - ESTRO32) ; SEP 27 - OCT 1, 2013; Amsterdam, NETHERLANDS.
[Keynote lecture]
Auer, M; Ulz, P; Pristauz, G; Petru, E; Jahn, S; Gasch, C; Riethdorf, S; Pantel, K; Geigl, JB; Speicher, MR; Heitzer, E
High-resolution molecular characterization of circulating cell-free DNA and circulating tumor cells of patients with metastatic breast cancer.
http://gfhev.de/de/kongress/GfH_Tagung_2013_Abstractbook.pdf. 2013; -24. Jahrestagung
der Deutschen Gesellschaft für Humangenetik ; MAR 20-22,2013; Dresden, GERMANY.
[Keynote lecture]
** Gincu, V; Kornprat, P; Thimary, F; Jahn, S; Mischinger, HJ
Intestinal obstruction caused by splenosis at the rectosigmoid junction, mimicking malignant pelvic tumor.
Endoscopy. 2011; 43 Suppl 2 UCTN(2):E260-E260
Doi: 10.1055/s-0030-1256523
(- Case Report)
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Jahn, SW; Liegl, B; Leskowschek, H; Spreizer, C; Langner, C
Angiosarcoma at the anastomotic site mimicking local recurrence of rectal adenocarcinoma.
Endoscopy. 2011; 43 Suppl 2 UCTN(7):E293-E294
Doi: 10.1055/s-0030-1256450
(- Case Report)
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Jahn, SW; Winter, G; Stacher, E; Halbwedl, I; Gattenlöhner, S; Stockinger, R; Spreitzer, S; Waldispuehl-Geigl, J; Geigl, JB; Offner, F; Hoefler, G
Multiple intratumoral KRAS mutations can clonally segregate to different lymph node metastases in colon cancer.
Histopathology. 2011; 59(2): 342-345.
Doi: 10.1111/j.1365-2559.2011.03902.x
(- Case Report)
Web of Science
PubMed
FullText
FullText_MUG
** Ausch, C; Buxhofer-Ausch, V; Oberkanins, C; Holzer, B; Minai-Pour, M; Jahn, S; Dandachi, N; Zeillinger, R; Kriegshäuser, G
Sensitive detection of KRAS mutations in archived formalin-fixed paraffin-embedded tissue using mutant-enriched PCR and reverse-hybridization.
J Mol Diagn. 2009; 11(6):508-513
Doi: 10.2353/jmoldx.2009.090022
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Jahn, S; Minai-Pour, MB; Speicher, MR; Reiner-Concin, A; Hoefler, G
Comprehensive screening for Lynch syndrome: who can be the driving force in daily clinical practice?
J CLIN ONCOL. 2009; 27(13): 2292-2292.
Doi: 10.1200/JCO.2009.22.0731
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar